One of the most challenging things to do is to quit smoking. That one last puff can only fuel cravings for another stick. Medical disclaimers and anti-smoking campaigns do nothing to curb your cravings for a nicotine fix.

Physicians and other health-care providers may advise their patients to quit smoking, but few providers have the adequate training to follow their patients through the cessation process.

Quitting smoking or as it is better know as smoking cessation, is when one tries to quit smoking or using tobacco based products. Tobacco based products have a addictive substance called Nicotine, in which is absorbed by the lungs of smokers when inhaled. When denied access to nicotine, they can have irritability, jitteriness, dry mouth and rapid heart beat. These physical symptoms are caused by withdrawals of nicotine, much like one has withdrawals of recreational drugs or alcohol.

Quitting smoking is one of the hardest things to do if you’re a chronic smoker. If you smoke more than 2 cigarettes a day, here are ways to help you quit smoking for good.

A mechanism in the body which typically helps a person heal from an injury, may actually be causing patients with idiopathic pulmonary fibrosis (IPF) to get worse, researchers at the National Institute of Environmental Health Sciences (NIEHS), a part of the National Institutes of Health (NIH), and their collaborators have found.

Evotec AG (Frankfurt Stock Exchange: EVT; NASDAQ: EVTC) announced today encouraging results of a Phase I safety study investigating the potential interaction of EVT 302, a reversible and highly selective inhibitor of monoamine oxidase B (MAO-B) in development for smoking cessation, with tyramine. The study was undertaken to determine potential safety advantages of EVT 302 versus non-selective MAO inhibitors and less selective MAO-B inhibitors already on the market.